Assignee
DNARx
US·3 granted patents·5 pending applications·6 citations·filing 2016–2023
Top patents by PatentIndex Score
8 records- 0184US10905777B2Systems and methods for nucleic acid expression in vivoDNARx·Filed 2018·Granted Feb 2, 2021·2 cites·28 claims
- 0283US10086089B2Systems and methods for nucleic acid expression in vivoDNARx·Filed 2016·Granted Oct 2, 2018·3 cites·21 claims
- 0382US2024350662A1Systems and methods for nucleic acid expression in vivoDNARx·Filed 2023·Application pending·0 cites
- 0478US11541130B2Systems and methods for nucleic acid expression in vivoDNARx·Filed 2018·Granted Jan 3, 2023·1 cites·10 claims
- 0566US2024033376A1Systems and methods for nucleic acid expression in vivoDNARx·Filed 2022·Application pending·0 cites
- 0662US2023212610A1Nucleic acid expression using subcutaneous administrationDNARx·Filed 2022·Application pending·0 cites
- 0761US2019083653A1Systems and Methods for Nucleic Acid Expression In VivoDNARx·Filed 2018·Application pending·0 cites
- 0860US2024156960A1Systems and methods for expressing biomolecules in a subjectDNARx·Filed 2023·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →